GAS6 and cancer: Targeting Gas6 or TAM receptors has emerged as a potential therapeutic strategy in cancer treatment; indeed, inhibiting the Gas6/TAM axis could potentially disrupt the pro-tumorigenic signaling pathways and enhance the effectiveness of anticancer therapies [112,113,114,115].